A Study to Decrease Suicidal Thinking Using Ketamine
Withdrawn
Depression treatment typically is slow acting. Patients presenting with acute suicidality have few immediate treatment options. However, sub-anesthetic doses of ketamine have been now widely tested as a rapid-acting treatment for depression. Gregory Larkin et al at Yale showed this could be applied to suicidal patients, with 14 of 15 participants showing remission of suicidal thinking within 40 min of the administration of ketamine, with 13 showing lasting remission out to 10 days. No serious si... Read More
Gender:
ALL
Ages:
Between 18 years and 65 years
Trial Updated:
08/29/2019
Locations: Naval Medical Center San Diego, San Diego, California
Conditions: Depression, Suicide
Subanesthetic IV Bolus Ketamine in the Treatment of Acute Depression
Terminated
The objective of this double-blinded placebo-controlled pilot study is to determine whether a single sub-anesthetic rapid IV bolus dose of ketamine administered to acutely depressed patients with or without suicidality has a significant rapid antidepressant effect in the acutely depressed population. The study will pursue as a primary outcome measure whether a significant reduction in depressive symptoms, as assessed by the BSS and BHS, occurs shortly after administration of ketamine at 40, 80,... Read More
Gender:
ALL
Ages:
Between 18 years and 65 years
Trial Updated:
03/03/2015
Locations: Naval Medical Center San Diego, San Diego, California
Conditions: Acute Depression